Gene · 4591
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mono- and biallelic variant effects on disease at biobank scale. | Nature | 2023 | 36653560 | PubTator, text mining | PubMed |
| A Retrospective Claims Database Study to Clarify Disease Burden of Severe Asthma Patients with Type 2 High or Low Inflammation. | J Asthma Allergy | 2023 | 36636701 | PubTator, text mining | PubMed |
| Impact of atrial fibrillation on the cognitive decline in Alzheimer's disease. | Alzheimers Res Ther | 2023 | 36635728 | PubTator, text mining | PubMed |
| Electron Correlation in the Iron(II) Porphyrin by Natural Orbital Functional Approximations. | J Chem Theory Comput | 2023 | 36579972 | PubTator, text mining | PubMed |
| Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | 36508011 | PubTator, text mining | PubMed |
| Glycoproteomic Analyses of Influenza A Viruses Using timsTOF Pro MS. | J Proteome Res | 2023 | 36480915 | PubTator, text mining | PubMed |
| CRISPR-Cas12a coupled with universal gold nanoparticle strand-displacement probe for rapid and sensitive visual SARS-CoV-2 detection. | Sens Actuators B Chem | 2023 | 36439054 | PubTator, text mining | PubMed |
| Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36411076 | PubTator, text mining | PubMed |
| High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients. | Blood | 2023 | 36399707 | PubTator, text mining | PubMed |
| Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36396447 | PubTator, text mining | PubMed |
| TRIM11, a new target of p53, facilitates the migration and invasion of nasopharyngeal carcinoma cells. | Mol Biol Rep | 2023 | 36376537 | PubTator, text mining | PubMed |
| Communication and Cross-Regulation between Chemically Fueled Sender and Receiver Reaction Networks. | Angew Chem Int Ed Engl | 2023 | 36354214 | PubTator, text mining | PubMed |
| Haploidentical CD3+ TCR αβ/CD19+-depleted HSCT for MHC class II deficiency and persistent SARS-CoV-2 pneumonitis. | J Allergy Clin Immunol Glob | 2023 | 36210925 | PubTator, text mining | PubMed |
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantation. | Haematologica | 2023 | 36200418 | PubTator, text mining | PubMed |
| Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis. | Blood Adv | 2023 | 36112425 | PubTator, text mining | PubMed |
| Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study. | Int J Hematol | 2023 | 36083572 | PubTator, text mining | PubMed |
| Proinflammatory microenvironment promotes lymphoma progression in mice with high megakaryocyte and TPO levels. | Blood Adv | 2023 | 36075025 | PubTator, text mining | PubMed |
| Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin. | Cell Mol Neurobiol | 2023 | 35896929 | PubTator, text mining | PubMed |
| Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway. | Dis Model Mech | 2023 | 35855640 | PubTator, text mining | PubMed |
| Alteration in Expression of Trim29, TRIM37, TRIM44, and β-Catenin Genes After Irradiation in Human Cells with Different Radiosensitivity. | Cancer Biother Radiopharm | 2023 | 32833505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4591/papers?page=12